Abstract
Light to moderate drinking in humans lowers the risk of coronary heart disease and may lower blood pressure. We examined the effect of chronic low daily alcohol consumption on blood pressure, platelet cytosolic free calcium [Ca2+]i, tissue aldehyde conjugates and renal vascular changes in normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR). We also examined the effects of the same weekly amount of alcohol consumption over a one day period each week simulating weekend drinking in humans. Animals, age 7 weeks, were divided into six groups of six animals each and were treated as follows: WKY and SHR control, normal drinking water; WKY and SHR, 0.5% ethanol in drinking water; WKY and SHR, 3.5% ethanol in drinking water one day/week. After 14 weeks systolic blood pressure, platelet [Ca2+]i, liver, kidney and aortic aldehyde conjugates were significantly higher (p < 0.05) in untreated SHRs as compared to untreated WKYs. Daily 0.5% ethanol consumption in SHRs significantly (p < 0.05) attenuated these changes and also attenuated smooth muscle cell hyperplasia and narrowing of the lumen in small arteries and arterioles of the kidney. WKY rats treated with 0.5% ethanol had lower aldehyde conjugates without any significant effect on blood pressure and platelet [Ca2+]i as compared to WKY controls. Consumption of 3.5% ethanol one day/week did not affect blood pressure and associated changes in normotensive WKY rats or hypertensive SHRs as compared to their respective controls. These results suggest that chronic daily low ethanol intake lowers blood pressure in SHRs by lowering tissue aldehyde conjugates and cytosolic free calcium.
Similar content being viewed by others
References
Jackson R, Scragg R, Beaglehole R: Alcohol consumption and risk of coronary heart disease. Br Med J 303: 211–216, 1991
Rimm EB, Klatsky A, Grobbee D, Stampfer MJ: Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits?. Br Med J 312: 731–736, 1996
Trevisan M, Dorn J: Alcohol and cardiovascular disease; what do we know? what should we do? Nutr Metab Cardiovas Dis 6: 111–113, 1996
Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Doll R: Alcohol consumption and mortality among middle-aged and elderly US Adults. N Engl J Med 337: 1705–1714, 1997
Klatsky AL, Friedman GD, Siegelaub AB, Gérard MJ: Alcohol consumption and blood pressure. N Engl J Med 296: 1194–1200, 1977
Jackson R, Stewart A, Beaglehole R, Scragg R: Alcohol consumption and blood pressure. A J Epid 122: 1037–1044, 1985
Ueshima H, Mikawa K, Baba S, Sasaki S, Ozawa H, Tsushima M, Kawaguchi A, Omae T, Katayama Y, Kayamori Y, Ito K: Effect of reduced alcohol consumption on blood pressure in untreated hypertensive men. Hypertension 21: 248–252, 1993
Beilin LJ: Alcohol and hypertension. Clin Exp Pharmacol Physiol 22: 185–188, 1995
Vasdev S, Mian T, Longerich L, Parai S: N-acetyl cysteine attenuates ethanol induced hypertension in rats. Artery 21: 312–336, 1995
Vasdev S, Sampson CA, Prabhakaran VM: Platelet-free calcium and vascular calcium uptake in ethanol-induced hypertensive rats. Hypertension 18: 116–122, 1991
Vasdev S, Mian T, Ford CA, Longerich L, Parai S: Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertensive rats. Nutr Metab Cardiovasc Dis 6: 130–140, 1996
Mandal AK, Bell RD, Parker D, Nordquist JA, Lindeman RD: An analysis of the relationship of the malignant lesions of the kidney to hypertension. Microvas Res 14: 279–292, 1977
Ludwig J: Current Methods of Autopsy Practice. W.B. Saunders Company, Philadelphia, pp. 343–344, 1972
Knupfer G: Drinking for health: the daily light drinker fiction. Br J Addic 82: 547–555, 1987
Thornalley PJ: Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem Soc Trans 21: 531–534, 1993
Vander Jagt DL, Hunsaker LA: Substrate specificity of reduced and oxidized forms of human aldose reductase. In: H.Y. Weiner (ed.). Enzymology and Molecular Biology of Carbonyl Metabolism 4. Plenum Press, New York, pp. 279–288, 1993
Leoncini G, Maresca M, Buzzi E: Inhibition of the glycolytic pathway by methylglyoxal in human platelets. Cell Biochem Function 7: 65–70, 1989
Vasdev S, Longerich L, Ford, CA: Role of aldehydes in hypertension. In: B.K. Sharma, N. Takeda, N.K. Ganguly, P.K. Singal (eds.). Adaptation Biology and Medicine (Vol I). Narosa Publishing House, New Delhi, India, pp. 326–339, 1997
Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S: Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery (submitted), 1998
Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J, Esterbaner H: Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J 227: 629–638, 1985
Benedetti A, Comporti M, Esterbauer H: Identification of 4-hyroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 620: 281–296, 1980
Dargel R: Lipid peroxidation-a common pathogenetic mechanism? Exp Toxic Pathol 44: 169–181, 1992
Uysal M, Bulur H, Sener D, Öz H: Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol 24: 474–476, 1986
Pontremoli S, Salamino F, Sparatore B, De Tullio R, Patrone M, Tizianello A, Melloni E: Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patients. Biochem Biophys Res Commun 158: 966–972, 1989
Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK: Oxygen free radicals in essential hypertension. Mol Cell Biochem 111: 103–108, 1992
Janero DR, Burghardt B: Cardiac membrane vitamin E and malondialdehyde levels in heart muscle of normotensive and spontaneouslyhypertensive rats. Lipids 24: 33–38, 1989
Vèricel E, Narce M, Ulmann L, Poisson J-P, Lagarde M: Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol Cell Biochem 132: 25–29, 1994
Uchida K, Stadtman ER: Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 268: 6388–6393, 1993
Schauenstein E, Esterbauer H, Zollner H: Aldehydes in biological systems. In: J.R. Lagnado (ed.). Aldehydes in biological systems, their natural occurrence and biological activities. Pion Limited, Brondesbury Park, London, pp. 1–7, 1977
Franco-Obregón A, Urena J, Lòpez-Barneo J: Oxygen-sensitive calcium channels in vascular smooth muscle and their possible role in hypoxic arterial relaxation. Proc Natl Acad Sci USA 92: 4715–4719, 1995
Murphy BJ, Washkurak AW, Tuana BS: Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups. Biochim Biophys Acta 1052: 333–339, 1990
Zaidi NF, Lagenaur CF, Abramson JJ, Pessah I, Salama G: Reactive disulfides trigger Ca2+ release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem 264: 21725–21736, 1989
Oba T, Yamaguchi M: Sulfhydryls on frog skeletal muscle membrane participate in contraction. Am J Physiol 259: C709–C714, 1990
Lieber CS: Mechanism of ethanol induced hepatic injury. Pharmac Ther 46: 1–41, 1990
Rodwell VW: Catabolism of the carbon skeletons of animo acids. In: R.K. Murray, D.K. Granner, P.A. Mayes, V.W. Rodwell (ed.). Harpers Biochemistry 24th edition. Appleton and Lange, Stanford, Connecticut 24: 314–315, 1996
Bolli P, Erne P, Hulthen UL, Ritz R, Kiowski W, Ji BH, Buhler FR: Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and badrenoceptor blockade. J Cardiovasc Pharmac 6: S996–S1001, 1984
Pollard TD. Electron microscopy of synthetic myosin filaments. J Cell Biol 67: 93–104, 1975
Vasdev S, Ford CA, Wadhawan S, Longerich L, Parai S, Gadag V: Dietary vitamin B6 supplementation prevents ethanol induced hypertension in rats. Nutr Metab Cardiovas Dis submitted, 1998
Bello AT, Bora NS, Lange LG, Bora PS: Cardioprotective effects of alcohol: mediation by human vascular alcohol dehydrogenase. Biochem Biophys Res Commun 203: 1858–1864, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vasdev, S., Ford, C.A., Longerich, L. et al. Antihypertensive effect of low ethanol intake in spontaneously hypertensive rats. Mol Cell Biochem 200, 85–92 (1999). https://doi.org/10.1023/A:1006950414560
Issue Date:
DOI: https://doi.org/10.1023/A:1006950414560